Washington [US], November 25 (ANI): A new study has found that exercising intensely at the start of a fast may help maximise the health benefits of temporarily foregoing food.
London [UK], November 23 (ANI): A new study has found that people who respond well to the recommended dietary therapy of restricting intake of fermentable carbs for irritable bowel syndrome, or IBS for short, have an abundance of particular types of bacteria in their gut.
Exeter [UK], November 23, (ANI): According to new research, people who are over 50 and suffer from poor sleep can also suffer from the negative perceptions of ageing that can affect their physical, mental and cognitive health.
Washington [US], November 22 (ANI): A new study has found that people who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors (a class of immunosuppressants), generated less powerful and shorter-lived antibodies against the virus that causes COVID-19 than healthy people
Tsukuba [Japan], November 21 (ANI): A new study has found that certain lifestyle habits play a significant role in the possibility of developing metabolic syndrome.
Washington [US], November 20 (ANI): A new research has found that caffeinated coffee consumption can have both beneficial and harmful short-term health effects.
Washington [US], November 20 (ANI): The findings of a study of health records from 87 health care centres across the United States have shown that people taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs) were less likely to die due to COVID-19.
Norwich [UK], November 19 (ANI): A new study has found that participation in workplace health and welfare programmes can improve the quality of work relationships and reduce bullying.
Ottawa [Canada], November 17 (ANI): A new study has shown how dexamethasone, the main treatment for severe COVID-19 lung infections, may help male patients but has little to no benefit for females.
Washington [US], November 16 (ANI): A new study of health records from 87 health care centres across the United States found that people taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs) were less likely to die of COVID-19.